- Home
-
Learn, develop, connect
Good Laboratory Practice for Study Directors, Principal Investigators, Study Staff and Management
9th - 10th September, Cambridge, UK
More information -
Membership
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information -
About us
News Archive
MHRA - policy for handling conflicts of interest
18th May 2022MHRA: policy for handling conflicts of interest - Uploaded the annual conflict of interest compliance report - 2021
MHRA - Drug Safety Update
18th May 2022MHRA - Uploaded the Drug Safety Update for May 2022
WHO - launches first ever global report on infection prevention and control
18th May 2022WHO launches first ever global report on infection prevention and control
MHRA Blog - Compliance Monitor Process (Part 2)– CM role and application process
11th May 2022Compliance Monitor Process (Part 2)– CM role and application process - a new blog post from the MHRA.
EMA - CTIS newsflash #11 - 22 April 2022
4th May 2022EMA - CTIS newsflash #11 - 22 April 2022
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022
4th May 2022EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022
EMA - Overview of comments on on ICH guideline Q9 (R1) on quality risk management
4th May 2022EMA have provided an overview of comments received between December 2021 and March 2022 on on ICH guideline Q9 (R1) on quality risk management.
MHRA - Compliance Monitor (CM) Overview and Application Process
4th May 2022From April 2022, the MHRA will be running a pilot scheme to monitor companies that fail to comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and are referred to the Inspection Action Group (IAG) after an inspection that has resulted in the compliance escalation process being initiated.
EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022
19th April 2022Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022
FDA - Request for Comments.- Cybersecurity in Medical Devices
19th April 2022FDA Request for Comments - Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us